Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs

被引:116
作者
Davis, Mark [1 ]
Walker, Gavin [2 ]
机构
[1] Univ Limerick, Bernal Inst, Synth & Solid State Pharmaceut Ctr SSPC, Limerick, Ireland
[2] Univ Limerick, Bernal Inst, Limerick, Ireland
基金
爱尔兰科学基金会;
关键词
Spray drying; Solid dispersion; Amorphous; Poorly soluble drugs; Formulation; AMORPHOUS SOLID DISPERSIONS; HOT-MELT EXTRUSION; ACTIVE PHARMACEUTICAL INGREDIENTS; RESPONSE-SURFACE MODEL; IN-VIVO EVALUATION; CLASS-II DRUG; DRIED DISPERSIONS; ORAL DELIVERY; PHYSICAL STABILITY; PHASE-BEHAVIOR;
D O I
10.1016/j.jconrel.2017.11.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poorly water-soluble drugs are a significant and ongoing issue for the pharmaceutical industry. An overview of recent developments for the preparation of spray-dried delivery systems is presented. Examples include amorphous solid dispersions, spray dried dispersions, microparticles, nanoparticles, surfactant systems and self-emulsifying drug delivery systems. Several aspects of formulation are considered, such as pre-screening, choosing excipient(s), the effect of polymer structure on performance, formulation optimisation, ternary dispersions, fixed-dose combinations, solvent selection and component miscibility. Process optimisation techniques including nozzle selection are discussed. Comparisons are drawn with other preparation techniques such as hot melt extrusion, freeze drying, milling, electro spinning and film casting. Novel analytical and dissolution techniques for the characterization of amorphous solid dispersions are included. Progress in understanding of amorphous supersaturation or recrystallisation from solution gathered from mechanistic studies is discussed. Aspects of powder flow and compression are considered in a section on downstream processing. Overall, spray drying has a bright future due to its versatility, efficiency and the driving force of poorly soluble drugs.
引用
收藏
页码:110 / 127
页数:18
相关论文
共 179 条
[1]   Understanding API-Polymer Proximities in Amorphous Stabilized Composite Drug Products Using Fluorine-Carbon 2D HETCOR Solid-State NMR [J].
Abraham, Anuji ;
Crull, George .
MOLECULAR PHARMACEUTICS, 2014, 11 (10) :3754-3759
[2]   Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions [J].
Adebisi, Adeola O. ;
Kaialy, Waseem ;
Hussain, Tariq ;
Al-Hamidi, Hiba ;
Nokhodchi, Ali ;
Conway, Barbara R. ;
Asare-Addo, Kofi .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 146 :841-851
[3]   Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions [J].
Al-Obaidi, Hisham ;
Lawrence, M. Jayne ;
Buckton, Graham .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2016, 68 (11) :1373-1383
[4]   Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus® processed by hot melt extrusion [J].
Albadarin, Ahmad B. ;
Potter, Catherine B. ;
Davis, Mark T. ;
Iqbal, Javed ;
Korde, Sachin ;
Pagire, Sudhir ;
Paradkar, Anant ;
Walker, Gavin .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 532 (01) :603-611
[5]   Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media [J].
Alhayali, Amani ;
Tavellin, Staffan ;
Velaga, Sitaram .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (01) :79-88
[6]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[7]   Combinatorial materials science: What's new since Edison? [J].
Amis, EJ ;
Xiang, XD ;
Zhao, JC .
MRS BULLETIN, 2002, 27 (04) :295-297
[8]  
[Anonymous], 2016, IMP GUID RES SOLV
[9]  
[Anonymous], 2015, PHARM LETT
[10]  
[Anonymous], INT J PHARM